Product Description
| Brand |
Wondfo |
| Sample Type |
Whole Blood |
| Pack Size |
24T |
| CAT No |
W481 |
The platform includes Semi-Automatic Blood Coagulation Analyzer and Optical Blood Coagulation. Our optical blood coagulation analyzer can test PT, APTT, TT, FIB, and ACT simultaneously, the first of its kind in the world.
Reliable APTT Testing for Clinical LaboratoriesWondfo Activated Partial Thromboplastin (APTT) Reagent enhances laboratory efficiency by delivering quick and accurate haemostasis screening. Its liquid, ready-to-use format allows for seamless integration into clinical workflows using automated or semi-automated coagulometers, thus ensuring consistent and high-precision results.
Versatile Compatibility and Easy HandlingEngineered for flexibility, this reagent supports a wide array of coagulometer instruments and requires minimal preparation. Sealed vials ensure product integrity, and its lightweight, portable design allows laboratories to optimize space and workflow. Each lot is clearly labeled, simplifying inventory and traceability.
FAQ's of Wondfo Activated Partial Thromboplastin (APTT):
Q: How should the Wondfo APTT Reagent be stored for optimal stability?
A: The reagent should be stored at 2-8C in its original sealed vial packaging. It must be kept away from direct sunlight to preserve its efficacy throughout its 12-month shelf life.
Q: What is the primary use of the Wondfo Activated Partial Thromboplastin (APTT) Reagent?
A: It is used for activated partial thromboplastin time (APTT) determination in human plasma, primarily for haemostasis screening and monitoring of heparin therapy in clinical and diagnostic laboratories.
Q: When should laboratories choose this specific APTT reagent?
A: Laboratories should use this reagent when they require fast, reliable, and sensitive APTT results for effective assessment of the coagulation pathway and monitoring patients on heparin therapy.
Q: Where can this reagent be utilized effectively?
A: The Wondfo APTT reagent is ideal for use in diagnostic laboratories, hospitals, and clinical centers equipped with semi-automated or automated coagulation analyzers.
Q: What is the process for conducting an APTT test using this reagent?
A: The test involves adding the ready-to-use reagent to a human plasma sample in a compatible coagulometer. The reagent reacts with plasma, and the instrument measures the time required for clot formation, providing a precise APTT value.
Q: What are the key benefits of choosing the Wondfo APTT reagent?
A: Key advantages include high sensitivity, quick turnaround time, ease of use, reliable performance, and validated precision by the manufacturer, supporting critical clinical decision-making.